Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib is safe and may effectively treat alopecia areata.

Hair transplantation can successfully treat stubborn alopecia areata.

Wet cupping and Rasayana Chikitsa may help regrow hair in alopecia areata.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

The treatment cleared psoriasis in some patients but caused side effects in most.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Baricitinib was effective in treating both early and late onset alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ruxolitinib treatment may cause eyelash growth.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.